 Lymphokine-activated killer cell activity lung cancer study local pulmonary immune effector cell lytic activity Purified lymphocyte populations BALF patients bronchogenic carcinoma patients lung disorders cancer normal control volunteers age smoking history cells NK LAK lytic activity NK-resistant LAK-sensitive tumor targets pulmonary tumor Daudi tumor cells NK-sensitive tumor LAK activity BALF patients cancer patients cancer subjects pulmonary disease cancer normal volunteers detectable lytic activity Peripheral blood lymphocytes subjects NK lytic activity pulmonary tumor target AMs tumoricidal LAK cell activation BALF patients pulmonary LAK lytic activity results LAK cells capable pulmonary tumor cells present BALF patients bronchogenic carcinoma lytic LAK cell population local pulmonary response lung cancer absence systemic tumoricidal activity functional status pulmonary immune effector cells type quantities cytokines lung local responsiveness carcinoma course disease